SYRS

Syros Pharmaceuticals, Inc. Common Stock

Delisted

SYRS was delisted on the 19th of March, 2025.

75 hedge funds and large institutions have $112M invested in Syros Pharmaceuticals, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 21 increasing their positions, 7 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
75
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$162K
Puts
$3K
Net Calls
Net Calls Change

Top Buyers

1 +$2.29M
2 +$2.17M
3 +$1.52M
4
Millennium Management
Millennium Management
New York
+$1.4M
5
Goldman Sachs
Goldman Sachs
New York
+$1.11M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$14.7M
2
$13.4M
3
$11.1M
4
$9.56M
5
$8.95M
6
$7.87M
7
$6.92M
8
$4.97M
9
$4.43M
10
$4.21M
11
$2.39M
12
$2.17M
13
$1.82M
14
$1.52M
15
$1.4M
16
$1.38M
17
$1.34M
18
$1.25M
19
$1.18M
20
$936K
21
$923K
22
$909K
23
$854K
24
$829K
25
$738K